Related Experiment Video
Updated: Oct 16, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated
Neil B Varshneya1, Sherif H Hassanien2, Melissa C Holt2
1Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Abstract:
Opioid-related fatalities involving synthetic opioids have reached unprecedented levels. This study evaluated the respiratory depressant effects of seven fentanyl analogs that have either emerged in the illicit drug supply or been identified in toxicological analyses following fatal or non-fatal intoxications. Adult male Swiss Webster mice were administered fentanyl analogs (isobutyrylfentanyl, crotonylfentanyl, para-methoxyfentanyl, para-methoxybutyrylfentanyl, 3-furanylfentanyl, thiophenefentanyl, and benzodioxolefentanyl) and their effects on minute volume as compared to mu-opioid receptor (MOR) agonist standards (fentanyl, morphine, and buprenorphine) were measured using whole body plethysmography (WBP). All drugs elicited significant (p ≤ 0.05) hypoventilation relative to vehicle for at least one dose tested: morphine (1, 3.2, 10, 32 mg/kg), buprenorphine, (0.032, 0.1, 0.32, 1, 3.2 mg/kg), fentanyl (0.0032, 0.01, 0.032, 0.1, 1, 32 mg/kg), isobutyrylfentanyl (0.1, 0.32, 1, 3.2, 10 mg/kg), crotonylfentanyl (0.1, 0.32, 1, 3.2, 10 mg/kg), para-methoxyfentanyl (0.1, 0.32, 1, 3.2, 10 mg/kg), para-methoxybutyrylfentanyl (0.32, 1, 3.2, 10 mg/kg), 3-furanylfentanyl (0.1, 0.32, 1, 3.2, 10 mg/kg), thiophenefentanyl (1, 3.2, 10, 32, 100 mg/kg), and benzodioxolefentanyl (3.2, 10, 32, 100 mg/kg). The ED50 values for hypoventilation showed a rank order of potency as follows: fentanyl (ED50 = 0.96 mg/kg) > 3-furanylfentanyl (ED50 = 2.60 mg/kg) > crotonylfentanyl (ED50 = 2.72 mg/kg) > para-methoxyfentanyl (ED50 = 3.31 mg/kg) > buprenorphine (ED50 = 10.8 mg/kg) > isobutyrylfentanyl (ED50 = 13.5 mg/kg) > para-methoxybutyrylfentanyl (ED50 = 16.1 mg/kg) > thiophenefentanyl (ED50 = 18.0 mg/kg) > morphine (ED50 = 55.3 mg/kg) > benzodioxolefentanyl (ED50 = 10,168 mg/kg). A naloxone pretreatment (10 mg/kg) attenuated the hypoventilatory effects of all drugs. These results establish that the respiratory depressant effects of these fentanyl analogs are at least in part mediated by the MOR.
Insights
This study assessed the respiratory depressant effects of seven fentanyl analogs in mice. All analogs caused hypoventilation, with potency varying significantly, indicating a risk associated with these synthetic opioids.
Area of Science:
- Pharmacology
- Toxicology
- Neuroscience
Background:
- Synthetic opioids, particularly fentanyl analogs, are a major cause of drug-related fatalities.
- Emerging fentanyl analogs in the illicit drug supply pose a significant public health threat.
- Understanding the respiratory depressant effects of these analogs is crucial for harm reduction and clinical management.
Purpose of the Study:
- To evaluate and compare the respiratory depressant potency of seven fentanyl analogs.
- To determine the role of the mu-opioid receptor (MOR) in the hypoventilatory effects of these analogs.
Main Methods:
- Adult male Swiss Webster mice were administered various doses of seven fentanyl analogs and standard MOR agonists (fentanyl, morphine, buprenorphine).
- Whole body plethysmography (WBP) was used to measure minute volume and assess hypoventilation.
- Naloxone pretreatment was employed to investigate the involvement of MOR.
Main Results:
- All tested fentanyl analogs induced significant dose-dependent hypoventilation compared to vehicle.
- A clear rank order of potency for hypoventilation was established, with fentanyl being the most potent and benzodioxolefentanyl the least potent among the analogs.
- Naloxone effectively attenuated the hypoventilatory effects, confirming MOR mediation.
Conclusions:
- The studied fentanyl analogs exhibit significant respiratory depressant properties mediated, at least in part, by the mu-opioid receptor.
- The varying potencies highlight the unpredictable risks associated with the use of novel synthetic opioids.
- These findings underscore the importance of monitoring and understanding the pharmacology of emerging synthetic opioids in public health surveillance.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
Parenteral Anesthetics: Overview
Analgesia and Pain Management
Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...

